Dr. Agarwal's Eye Hospital Shows Strong Financial Growth Amid Rising Interest Expenses and Pledged Shares
Dr. Agarwal's Eye Hospital has experienced an evaluation adjustment due to significant changes in its financial metrics. The company reported a strong quarterly performance with notable growth in net sales and operating profit. However, it faces challenges from rising interest expenses and a high percentage of pledged promoter shares.
Dr. Agarwal's Eye Hospital has recently undergone an evaluation adjustment, reflecting notable changes in its financial metrics and technical indicators. The company reported a positive financial performance for the quarter ending March 2025, with net sales reaching Rs 99.83 crore, marking a growth of 23.67%. Additionally, the PBDIT reached its highest level at Rs 31.59 crore, and the operating profit to net sales ratio stood at 31.64%, indicating strong operational efficiency.On the technical side, the stock's trend has shifted from a mildly bearish stance to a sideways movement, suggesting a period of stabilization without clear momentum. The MACD indicators show a mildly bullish trend on a weekly basis, while the monthly outlook remains mildly bearish.
Despite the positive financial results, the company faces challenges, including a significant increase in interest expenses, which grew by 51.09% over the past nine months. Furthermore, a notable portion of promoter shares, 55.45%, are pledged, which could exert additional pressure in volatile market conditions.
Overall, the evaluation adjustment reflects a complex interplay of strong financial performance and technical trends, positioning Dr. Agarwal's Eye Hospital in a unique market context.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
